skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: EBSCO_MEDLINE Complete（医学期刊全文数据库） remover idioma: Inglês remover Journal Of Clinical Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
EGFR ligands and ERCC1 mRNA expression to predict clinical outcome in Japanese (JPN) patients (pts) with metastatic colorectal cancer (mCRC) harboring overexpressed EGFR and KRAS exon 2 wild-type ( KRAS wt) treated with cetuximab (cet) plus oxaliplatin-based chemotherapy (JACCRO CC-05/06 AR)
EGFR ligands and ERCC1 mRNA expression to predict clinical outcome in Japanese (JPN) patients (pts) with metastatic colorectal cancer (mCRC) harboring overexpressed EGFR and KRAS exon 2 wild-type ( KRAS wt) treated with cetuximab (cet) plus oxaliplatin-based chemotherapy (JACCRO CC-05/06 AR)
Material Type:
Artigo 		Adicionar ao Meu Espaço

EGFR ligands and ERCC1 mRNA expression to predict clinical outcome in Japanese (JPN) patients (pts) with metastatic colorectal cancer (mCRC) harboring overexpressed EGFR and KRAS exon 2 wild-type ( KRAS wt) treated with cetuximab (cet) plus oxaliplatin-based chemotherapy (JACCRO CC-05/06 AR)

Sunakawa, Yu ; Ichikawa, Wataru ; Tsuji, Akihito ; Moran, Miriana ; Astrow, Stephanie H. ; Yang, Dongyun ; Zhang, Wu ; Takahashi, Takehiro ; Denda, Tadamichi ; Shimada, Ken ; Kochi, Mitsugu ; Nakamura, Masato ; Kotaka, Masahito ; Segawa, Yoshihiko ; Takeuchi, Masahiro ; Lenz, Heinz-Josef ; Fujii, Masashi ; Nakajima, Toshifusa

Journal of clinical oncology, 2015-01, Vol.33 (3_suppl), p.618-618 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
2
Impacts of T and N factors on curability of pancreatic, gastric, and colonic cancers
Impacts of T and N factors on curability of pancreatic, gastric, and colonic cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impacts of T and N factors on curability of pancreatic, gastric, and colonic cancers

Maetani, S. ; Segawa, Y. ; Banja, H. ; Obayashi, H. ; Imamura, M. ; Gamel, J. W.

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e21042-e21042 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
3
A randomized phase III study of cisplatin and docetaxel with or without irinotecan in pts with advanced non-small cell lung cancer: Okayama Lung Cancer Study Group OLCSG 0403
A randomized phase III study of cisplatin and docetaxel with or without irinotecan in pts with advanced non-small cell lung cancer: Okayama Lung Cancer Study Group OLCSG 0403
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized phase III study of cisplatin and docetaxel with or without irinotecan in pts with advanced non-small cell lung cancer: Okayama Lung Cancer Study Group OLCSG 0403

Kiura, K. ; Tabata, M. ; Takigawa, N. ; Kuyama, S. ; Segawa, Y. ; Kamei, H. ; Shibayama, T. ; Hotta, K. ; Matsuo, K. ; Tanimoto, M.

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.7584-7584 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
4
A randomized phase II study of a combination of docetaxel and S-1 versus docetaxel monotherapy in pts with NSCLC previously treated with platinum-based chemotherapy: Results of Okayama Lung Cancer Study Group (OLCSG) trial 0503
A randomized phase II study of a combination of docetaxel and S-1 versus docetaxel monotherapy in pts with NSCLC previously treated with platinum-based chemotherapy: Results of Okayama Lung Cancer Study Group (OLCSG) trial 0503
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized phase II study of a combination of docetaxel and S-1 versus docetaxel monotherapy in pts with NSCLC previously treated with platinum-based chemotherapy: Results of Okayama Lung Cancer Study Group (OLCSG) trial 0503

Segawa, Y. ; Hotta, K. ; Takigawa, N. ; Matsuo, K. ; Yoshioka, H. ; Hayashi, H. ; Nogami, N. ; Tabata, M. ; Kiura, K. ; Tanimoto, M.

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.8058-8058 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
Randomized phase III trial of docetaxel and cisplatin combination chemotherapy versus mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer: OLCSG 0007
Randomized phase III trial of docetaxel and cisplatin combination chemotherapy versus mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer: OLCSG 0007
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized phase III trial of docetaxel and cisplatin combination chemotherapy versus mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer: OLCSG 0007

Kiura, K. ; Takigawa, N. ; Segawa, Y. ; Kamei, H. ; Takemoto, M. ; Tabata, M. ; Ueoka, H. ; Hiraki, S. ; Matsuo, K. ; Tanimoto, M.

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.7515-7515 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Data de Publicação 

De até
Refinar
  1. Antes de2008  (1)
  2. 2008Até2008  (1)
  3. 2009Até2009  (1)
  4. 2010Até2011  (2)
  5. Após 2011  (1)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.